檢索結果 - Xuewei Cui

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology

    Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology 由 So Young Ji, Cheng Jin, Xuewei Cui

    出版 2025
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study

    Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study 由 Xuewei Cui, Yongyan Shi, Siyang Gao, Xindong Xue, Jianhua Fu

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Toll-like receptor 4-mediated necroptosis in the development of necrotizing enterocolitis

    Toll-like receptor 4-mediated necroptosis in the development of necrotizing enterocolitis 由 Tianjing Liu, Haifeng Zong, Xiaoyu Chen, Sihang Li, Ziyun Liu, Xuewei Cui, Guoqiang Jia, Yongyan Shi

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program

    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program 由 Ildiko Lingvay, Ofri Mosenzon, Katelyn Brown, Xuewei Cui, Ciara O’Neill, Laura Fernández Landó, Hiren Patel

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer

    CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer 由 Jinglue Song, Wei‐Fan Chen, Xuewei Cui, Zhenyu Huang, Dongpeng Wen, Yili Yang, Wei Yu, Long Cui, Chen‐Ying Liu

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

    Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes 由 Melissa K. Thomas, Amir Nikooienejad, Ross Bray, Xuewei Cui, Jonathan M. Wilson, Kevin L. Duffin, Zvonko Miličević, Axel Haupt, Deborah Robins

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

    Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week,... 由 Juan P. Frías, Michael A. Nauck, Joanna Van, Charles T. Benson, Ross Bray, Xuewei Cui, Zvonko Miličević, Shweta Urva, Axel Haupt, Deborah Robins

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (<scp>GLP</scp>‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective <scp>long‐acting GLP</scp>‐1 receptor agonists

    The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (<scp>GLP</scp>‐1) receptor agonist tirzepatide transiently delays gastric emptying similarl... 由 Shweta Urva, Tamer Coşkun, Corina Loghin, Xuewei Cui, Emily Beebe, Libbey S. O’Farrell, Daniel A. Briere, Charles T. Benson, Michael A. Nauck, Axel Haupt

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes 由 Juan P. Frías, Melanie J. Davies, Julio Rosenstock, Federico C. Pérez Manghi, Laura Fernández Landó, Brandon K. Bergman, Bing Liu, Xuewei Cui, Katelyn Brown

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

    LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept 由 Tamer Coşkun, Kyle W. Sloop, Corina Loghin, Jorge Alsina‐Fernandez, Shweta Urva, Krister Bokvist, Xuewei Cui, Daniel A. Briere, Over Cabrera, William C. Roell, Uma Kuchibhotla, Julie S. Moyers, Charles T. Benson, Ruth E. Gimeno, David A. D’Alessio, Axel Haupt

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: